Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Arthritis Rheumatol. 2016 Jun;68(6):1432–1441. doi: 10.1002/art.39594

Figure 3.

Figure 3

Estimated risk (solid lines) of end-stage renal disease (ESRD) at 5 years, 10 years, and 15 years in developed and developing countries, including data for given studies from the midpoint of enrollment to the end of observation, truncating the study’s contribution at 10 years after the midpoint of enrollment for any study for which follow-up longer than 10 years was reported. Dashed lines represent 95% confidence limits.